IRIS Accounts Production v22.2.0.402 11076871 Board of Directors Board of Directors 1.12.20 30.11.21 30.11.21 0 0 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure110768712020-11-30110768712021-11-30110768712020-12-012021-11-30110768712019-11-30110768712019-12-012020-11-30110768712020-11-3011076871ns16:EnglandWales2020-12-012021-11-3011076871ns15:PoundSterling2020-12-012021-11-3011076871ns11:Director12020-12-012021-11-3011076871ns11:Director22020-12-012021-11-3011076871ns11:PrivateLimitedCompanyLtd2020-12-012021-11-3011076871ns11:SmallEntities2020-12-012021-11-3011076871ns11:AuditExempt-NoAccountantsReport2020-12-012021-11-3011076871ns11:SmallCompaniesRegimeForDirectorsReport2020-12-012021-11-3011076871ns11:SmallCompaniesRegimeForAccounts2020-12-012021-11-3011076871ns11:FullAccounts2020-12-012021-11-301107687112020-12-012021-11-3011076871ns11:RegisteredOffice2020-12-012021-11-3011076871ns6:CurrentFinancialInstruments2021-11-3011076871ns6:CurrentFinancialInstruments2020-11-3011076871ns6:ShareCapital2021-11-3011076871ns6:ShareCapital2020-11-3011076871ns6:RetainedEarningsAccumulatedLosses2021-11-3011076871ns6:RetainedEarningsAccumulatedLosses2020-11-3011076871ns6:IntangibleAssetsOtherThanGoodwill2020-12-012021-11-3011076871ns6:ComputerSoftware2020-12-012021-11-3011076871ns6:PlantMachinery2020-12-012021-11-3011076871ns6:IntangibleAssetsOtherThanGoodwill2020-11-3011076871ns6:IntangibleAssetsOtherThanGoodwill2021-11-3011076871ns6:IntangibleAssetsOtherThanGoodwill2020-11-3011076871ns6:PlantMachinery2020-11-3011076871ns6:PlantMachinery2021-11-3011076871ns6:PlantMachinery2020-11-3011076871ns6:WithinOneYearns6:CurrentFinancialInstruments2021-11-3011076871ns6:WithinOneYearns6:CurrentFinancialInstruments2020-11-3011076871ns11:Director112020-11-3011076871ns11:Director112019-11-3011076871ns11:Director112020-12-012021-11-3011076871ns11:Director112019-12-012020-11-3011076871ns11:Director112021-11-3011076871ns11:Director112020-11-30
REGISTERED NUMBER: 11076871 (England and Wales)















Ayur Medical Ltd.

Unaudited Financial Statements for the Year Ended 30 November 2021






Ayur Medical Ltd. (Registered number: 11076871)






Contents of the Financial Statements
for the Year Ended 30 November 2021




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


Ayur Medical Ltd.

Company Information
for the Year Ended 30 November 2021







DIRECTORS: Professor I Manyonda
V Sinai Talaulikar





REGISTERED OFFICE: 11 Hindmarsh Crescent
Northfleet
Gravesend
Kent
DA11 8FD





BUSINESS ADDRESS: 10 Harley Street
Marylebone
London
W1G 9PF





REGISTERED NUMBER: 11076871 (England and Wales)





ACCOUNTANTS: Aggarwal & Co Limited
Chartered Accountants
5 London Road
Rainham
Gillingham
Kent
ME8 7RG

Ayur Medical Ltd. (Registered number: 11076871)

Statement of Financial Position
30 November 2021

2021 2020
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - 95
Tangible assets 5 6,144 7,680
6,144 7,775

CURRENT ASSETS
Debtors 6 - 759
Cash at bank 31,610 14,083
31,610 14,842
CREDITORS
Amounts falling due within one year 7 32,336 27,624
NET CURRENT LIABILITIES (726 ) (12,782 )
TOTAL ASSETS LESS CURRENT LIABILITIES 5,418 (5,007 )

PROVISIONS FOR LIABILITIES 1,167 -
NET ASSETS/(LIABILITIES) 4,251 (5,007 )

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 4,151 (5,107 )
SHAREHOLDERS' FUNDS 4,251 (5,007 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2021 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Ayur Medical Ltd. (Registered number: 11076871)

Statement of Financial Position - continued
30 November 2021


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 August 2022 and were signed on its behalf by:




V Sinai Talaulikar - Director



Professor I Manyonda - Director


Ayur Medical Ltd. (Registered number: 11076871)

Notes to the Financial Statements
for the Year Ended 30 November 2021

1. STATUTORY INFORMATION

Ayur Medical Ltd. is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Income recognition
Income represents the fair value of consideration received or receivable derived from the services to customers during the year and is recognised when the company becomes entitled to it, usually on the rendering of an invoice.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Computer software is being amortised evenly over its estimated useful life of three years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Plant and machinery etc - 20% on reducing balance

Financial instruments
The Company enters into basic financial instruments that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable which are measured at fair value, with changes recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Ayur Medical Ltd. (Registered number: 11076871)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2021

2. ACCOUNTING POLICIES - continued

Going concern
The impact of the COVID-19 virus has been assessed by the directors so far as reasonably possible, due to its unprecedented impact on the wider economy, it is difficult to evaluate with any certainty the potential outcomes on the company's trade, its customers and suppliers.
However, taking into consideration the UK Government's financial support and the directors planning and personal support, the directors have a reasonable expectation that the company will continue in operational existence for the foreseeable future.

Included within creditors is an amount of £27,000 owed to a director Professor I Manyonda. The company is dependent on the financial support of this director, who has continued to provide this support since the year end. The director has confirmed that this amount will not be withdrawn until there are sufficient funds to do so. On this basis, the director considers it appropriate to prepare financial statements on the going concern basis.

Government grants
Government grants in relation to COVID-19 are recognised on the accruals basis and credited to the Income Statement and any related expenditure is charged to the Income Statement.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2020 - NIL).

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 December 2020
and 30 November 2021 1,716
AMORTISATION
At 1 December 2020 1,621
Charge for year 95
At 30 November 2021 1,716
NET BOOK VALUE
At 30 November 2021 -
At 30 November 2020 95

Ayur Medical Ltd. (Registered number: 11076871)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2021

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 December 2020
and 30 November 2021 12,000
DEPRECIATION
At 1 December 2020 4,320
Charge for year 1,536
At 30 November 2021 5,856
NET BOOK VALUE
At 30 November 2021 6,144
At 30 November 2020 7,680

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Other debtors - 759

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Taxation and social security 615 -
Other creditors 31,721 27,624
32,336 27,624

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 November 2021 and 30 November 2020:

2021 2020
£    £   
V Sinai Talaulikar
Balance outstanding at start of year 759 -
Amounts advanced - 759
Amounts repaid (759 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - 759